Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  04/29/2011
 
Trade Name:  Nexium IV
 
Generic Name or Proper Name (*):  esomeprazole
 
Indications Studied:  Treatment of Gastroesophageal Reflux Disease (GERD) with erosive esophagitis
 
Label Changes Summary:  Extended indication from adults to pediatric patients 1 month to 17 years Use in pediatric patients 1 month to 17 years is supported by studies in adults, and PK and PD studies performed in pediatric patientsEffectiveness has not been established in patients less than 1 month of ageInformation on dosing, adverse reactions, pharmacokinetics and clinical trialPostmarketing study
 
Product Labeling:  Labeling  Opens a new window
 
PREA(P):  P
 
Sponsor:  AstraZeneca
 
NNPS:  FALSE'
 
Therapeutic Category:  Antiulcerative
 
-
-